Clinical Trials Browser

Phase 3 × Advanced Breast Cancer × apatinib × Clear all

NCT06447623 2024-06-07

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Phase 3 Recruiting

Advanced Breast Cancer